Á lódáil...

Expanding role of lenalidomide in hematologic malignancies

Lenalidomide is an immunomodulatory agent that has been approved by the US Food and Drug Administration for treatment of multiple myeloma, deletion 5q myelodysplastic syndrome, and mantle cell lymphoma. In addition, it has clinical activity in lymphoproliferative disorders and acute myeloid leukemia...

Cur síos iomlán

Na minha lista:
Sonraí Bibleagrafaíochta
Foilsithe in:Cancer Manag Res
Main Authors: Ghosh, Nilanjan, Grunwald, Michael R, Fasan, Omotayo, Bhutani, Manisha
Formáid: Artigo
Teanga:Inglês
Foilsithe: Dove Medical Press 2015
Ábhair:
Rochtain Ar Líne:https://ncbi.nlm.nih.gov/pmc/articles/PMC4427066/
https://ncbi.nlm.nih.gov/pubmed/25999761
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CMAR.S81310
Clibeanna: Cuir Clib Leis
Gan Chlibeanna, Bí ar an gcéad duine leis an taifead seo a chlibeáil!